John S Bomalaski, MD
Polaris Group
2
0
1
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Anne S. Tsao, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Barbara Gitlitz, MD
University of Southern California
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Michael Offin, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Rufus Scrimger, MD
AHS Cancer Control Alberta
Shared therapeutic areas:
Emil Kuriakose, MD
Calithera Biosciences, Inc
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Yifan Zhai, MD, PhD
Ascentage Pharma Group Inc.
Shared therapeutic areas:
Sven Gogov, MD
Incyte Corporation
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin
All 2 trials loaded